Stock Scorecard



Stock Summary for Qiagen NV (QGEN) - $39.85 as of 3/28/2025 8:49:04 PM EST

Total Score

9 out of 30

Safety Score

54 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for QGEN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for QGEN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for QGEN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for QGEN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for QGEN (54 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 6
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 1
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for QGEN

Laboratory Robotics Market Set to Grow at 6.6% CAGR, Reaching US$ 548.6 Million by 2034 Amid Increasing Adoption in Pharma and Biotech | Transparency Market Research, Inc. 3/21/2025 3:14:00 PM
HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip? 3/19/2025 1:57:00 PM
Is it Worth Retaining QIAGEN Stock in Your Portfolio Now? 3/12/2025 10:54:00 AM
$6.7 Billion Laboratory Consumables Market by 2034: Growth in Germany, Belgium, and Netherlands Fueled by Increasing R&D Investments - Analysis by TMR 3/11/2025 12:07:00 PM
Manchester looks to build on life sciences cluster effect 3/10/2025 4:00:00 AM
Qiagen ( QGEN ) Down 6% Since Last Earnings Report: Can It Rebound? 3/7/2025 4:31:00 PM
QGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal Panel 3/7/2025 11:35:00 AM
Molecular Infectious Disease Testing Market to Hit US$17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™. 3/5/2025 12:30:00 PM
Hologic Wins Key Approvals Post Q1 Results: Buy or Hold HOLX Stock? 2/26/2025 1:03:00 PM
2 Recent Stock Splits You've Never Heard of That Certain Wall Street Analysts Think Could Soar 39% and 62% 2/23/2025 12:00:00 PM

Financial Details for QGEN

Company Overview

Ticker QGEN
Company Name Qiagen NV
Country USA
Description QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 12/31/2024
Next Earnings Date 4/30/2025

Stock Price History

Last Day Price 39.85
Price 4 Years Ago 55.67
Last Day Price Updated 3/28/2025 8:49:04 PM EST
Last Day Volume 868,833
Average Daily Volume 1,077,563
52-Week High 47.96
52-Week Low 37.63
Last Price to 52 Week Low 5.90%

Valuation Measures

Trailing PE 104.16
Industry PE 53.93
Sector PE 40.10
5-Year Average PE 21.61
Free Cash Flow Ratio 12.98
Industry Free Cash Flow Ratio 18.14
Sector Free Cash Flow Ratio 47.05
Current Ratio Most Recent Quarter 3.61
Total Cash Per Share 3.07
Book Value Per Share Most Recent Quarter 16.05
Price to Book Ratio 2.40
Industry Price to Book Ratio 11.03
Sector Price to Book Ratio 21.92
Price to Sales Ratio Twelve Trailing Months 4.33
Industry Price to Sales Ratio Twelve Trailing Months 59.91
Sector Price to Sales Ratio Twelve Trailing Months 27.78
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 4

Share Statistics

Total Shares Outstanding 216,115,000
Market Capitalization 8,612,182,750
Institutional Ownership N/A

Dividends

Ex-Dividend Date 1/29/2025
Previous Dividend Amount 1.2960
Current Dividend Amount 1.3166
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 1.32
Trailing Annual Dividend Yield 3.31%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 2
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio 346.47%

Income Statement

Quarterly Earnings Growth YOY -9.90%
Annual Earnings Growth -75.51%
Reported EPS 12 Trailing Months 0.38
Reported EPS Past Year 2.19
Reported EPS Prior Year 2.07
Net Income Twelve Trailing Months 83,591,000
Net Income Past Year 83,591,000
Net Income Prior Year 341,303,000
Quarterly Revenue Growth YOY 2.40%
5-Year Revenue Growth 5.32%
Operating Margin Twelve Trailing Months 27.70%

Balance Sheet

Total Cash Most Recent Quarter 663,555,000
Total Cash Past Year 663,555,000
Total Cash Prior Year 668,084,000
Net Cash Position Most Recent Quarter -701,029,000
Net Cash Position Past Year -258,269,000
Long Term Debt Past Year 921,824,000
Long Term Debt Prior Year 921,824,000
Total Debt Most Recent Quarter 1,364,584,000
Equity to Debt Ratio Past Year 0.79
Equity to Debt Ratio Most Recent Quarter 0.72
Total Stockholder Equity Past Year 3,567,339,000
Total Stockholder Equity Prior Year 3,807,764,000
Total Stockholder Equity Most Recent Quarter 3,567,339,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 503,274,000
Free Cash Flow Per Share Twelve Trailing Months 2.33
Free Cash Flow Past Year 506,377,000
Free Cash Flow Prior Year 296,653,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.36
MACD Signal -0.61
20-Day Bollinger Lower Band 37.45
20-Day Bollinger Middle Band 42.48
20-Day Bollinger Upper Band 47.51
Beta 0.44
RSI 51.21
50-Day SMA 43.19
150-Day SMA 44.39
200-Day SMA 46.01

System

Modified 3/28/2025 5:35:10 AM EST